+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Spinal Muscular Atrophy Market and Competitive Landscape - 2020

  • ID: 5023500
  • Report
  • April 2020
  • Region: Global
  • Fore Pharma
1 of 2
The research report Global Spinal Muscular Atrophy Market and Competitive Landscape - 2020, provides comprehensive insights into the Spinal Muscular Atrophy pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Spinal Muscular Atrophy market size and drug sales. It also provides insights into Spinal Muscular Atrophy epidemiology and late stage pipeline.

This research covers the following: Spinal Muscular Atrophy treatment options, Spinal Muscular Atrophy late stage clinical trials pipeline, Spinal Muscular Atrophy prevalence by countries, Spinal Muscular Atrophy market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:
  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
  • Spinal Muscular Atrophy pipeline: Find out drugs in clinical trials for the treatment of Spinal Muscular Atrophy by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Spinal Muscular Atrophy epidemiology: Find out the number of patients diagnosed (prevalence) with Spinal Muscular Atrophy by countries
  • Spinal Muscular Atrophy drugs: Identify key drugs marketed and prescribed for Spinal Muscular Atrophy in the US, including trade name, molecule name, and company
  • Spinal Muscular Atrophy drugs sales: Find out the sales value for Spinal Muscular Atrophy drugs by countries
  • Spinal Muscular Atrophy market valuations: Find out the market size for Spinal Muscular Atrophy drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Spinal Muscular Atrophy drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Spinal Muscular Atrophy drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Spinal Muscular Atrophy market
  • Develop in-depth knowledge of competition and markets
  • Analyze Spinal Muscular Atrophy drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Spinal Muscular Atrophy market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Spinal Muscular Atrophy Treatment Options

2. Spinal Muscular Atrophy Pipeline Insights
2.1. Spinal Muscular Atrophy Phase 3 Clinical Trials
2.2. Spinal Muscular Atrophy Phase 2 Clinical Trials
2.3. Spinal Muscular Atrophy Phase 1 Clinical Trials

3. Spinal Muscular Atrophy Epidemiology Analysis by Countries

4. US Spinal Muscular Atrophy Market Insights
4.1. Marketed Drugs for Spinal Muscular Atrophy in US
4.2. US Spinal Muscular Atrophy Market Size & Forecast
4.3. US Spinal Muscular Atrophy Drugs Sales & Forecast
4.4. US Spinal Muscular Atrophy Market Share Analysis

5. Germany Spinal Muscular Atrophy Market Insights
5.1. Marketed Drugs for Spinal Muscular Atrophy in Germany
5.2. Germany Spinal Muscular Atrophy Market Size & Forecast
5.3. Germany Spinal Muscular Atrophy Drugs Sales Forecast
5.4. Germany Spinal Muscular Atrophy Market Share Analysis

6. France Spinal Muscular Atrophy Market Insights
6.1. Marketed Drugs for Spinal Muscular Atrophy in France
6.2. France Spinal Muscular Atrophy Market Size & Forecast
6.3. France Spinal Muscular Atrophy Product Sales Forecast
6.4. France Spinal Muscular Atrophy Market Share Analysis

7. Italy Spinal Muscular Atrophy Market Insights
7.1. Marketed Drugs for Spinal Muscular Atrophy in Italy
7.2. Italy Spinal Muscular Atrophy Market Size & Forecast
7.3. Italy Spinal Muscular Atrophy Product Sales Forecast
7.4. Italy Spinal Muscular Atrophy Market Share Analysis

8. Spain Spinal Muscular Atrophy Market Insights
8.1. Marketed Drugs for Spinal Muscular Atrophy in Spain
8.2. Spain Spinal Muscular Atrophy Market Size & Forecast
8.3. Spain Spinal Muscular Atrophy Product Sales Forecast
8.4. Spain Spinal Muscular Atrophy Market Share Analysis

9. UK Spinal Muscular Atrophy Market Insights
9.1. Marketed Drugs for Spinal Muscular Atrophy in UK
9.2. UK Spinal Muscular Atrophy Market Size & Forecast
9.3. UK Spinal Muscular Atrophy Product Sales Forecast
9.4. UK Spinal Muscular Atrophy Market Share Analysis

10. Europe Spinal Muscular Atrophy Market Insights
10.1. Europe Spinal Muscular Atrophy Market Size & Forecast
10.2. Europe Spinal Muscular Atrophy Product Sales Forecast
10.3. Europe Spinal Muscular Atrophy Market Share Analysis

11. Japan Spinal Muscular Atrophy Market Insights
11.1. Marketed Drugs for Spinal Muscular Atrophy in Japan
11.2. Japan Spinal Muscular Atrophy Market Size & Forecast
11.3. Japan Spinal Muscular Atrophy Product Sales Forecast
11.4. Japan Spinal Muscular Atrophy Market Share Analysis

12. Global Spinal Muscular Atrophy Market Insights
12.1. Global Spinal Muscular Atrophy Market Size & Forecast
12.2. Global Spinal Muscular Atrophy Product Sales Forecast
12.3. Global Spinal Muscular Atrophy Market Share Analysis

13. Research Methodology

List of Tables
Table 1: Spinal Muscular Atrophy Phase 3 Clinical Trials, Global, 2020
Table 2: Spinal Muscular Atrophy Phase 2 Clinical Trials, Global, 2020
Table 3: Spinal Muscular Atrophy Phase 1 Clinical Trials, Global, 2020
Table 4: Spinal Muscular Atrophy Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Spinal Muscular Atrophy in US, 2019
Table 6: US Spinal Muscular Atrophy Market Size & Forecast ($mn), 2016 - 2024
Table 7: US Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Table 8: US Spinal Muscular Atrophy Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Spinal Muscular Atrophy in Germany, 2019
Table 10: Germany Spinal Muscular Atrophy Market Size & Forecast ($mn), 2016 - 2024
Table 11: Germany Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Table 12: Germany Spinal Muscular Atrophy Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Spinal Muscular Atrophy in France, 2019
Table 14: France Spinal Muscular Atrophy Market Size & Forecast ($mn), 2016 - 2024
Table 15: France Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Table 16: France Spinal Muscular Atrophy Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Spinal Muscular Atrophy in Italy, 2019
Table 18: Italy Spinal Muscular Atrophy Market Size & Forecast ($mn), 2016 - 2024
Table 19: Italy Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Table 20: Italy Spinal Muscular Atrophy Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Spinal Muscular Atrophy in Spain, 2019
Table 22: Spain Spinal Muscular Atrophy Market Size & Forecast ($mn), 2016 - 2024
Table 23: Spain Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Table 24: Spain Spinal Muscular Atrophy Market Events and Trends, 2016 - 2024
Table 25: Marketed Drugs for Spinal Muscular Atrophy in UK, 2019
Table 26: UK Spinal Muscular Atrophy Market Size & Forecast ($mn), 2016 - 2024
Table 27: UK Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Table 28: UK Spinal Muscular Atrophy Market Events and Trends, 2016 - 2024
Table 29: Europe Spinal Muscular Atrophy Market Size & Forecast ($mn), 2016 - 2024
Table 30: Europe Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Table 31: Marketed Drugs for Spinal Muscular Atrophy in Japan, 2019
Table 32: Japan Spinal Muscular Atrophy Market Size & Forecast ($mn), 2016 - 2024
Table 33: Japan Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Table 34: Japan Spinal Muscular Atrophy Market Events and Trends, 2016 - 2024
Table 35: Global Spinal Muscular Atrophy Market Size & Forecast ($mn), 2016 - 2024
Table 36: Global Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Spinal Muscular Atrophy Pipeline by Phase (%), Global, 2020
Figure 2: Spinal Muscular Atrophy Prevalence by Countries, 2016 - 2024
Figure 3: US Spinal Muscular Atrophy Market Size ($mn), 2016 - 2024
Figure 4: US Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Figure 5: US Spinal Muscular Atrophy Market Share by Drugs (%), 2019
Figure 6: US Spinal Muscular Atrophy Market - Future Market Share (%), 2024
Figure 7: Germany Spinal Muscular Atrophy Market Size ($mn), 2016 - 2024
Figure 8: Germany Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Figure 9: Germany Spinal Muscular Atrophy Market Share by Drugs (%), 2019
Figure 10: Germany Spinal Muscular Atrophy Market - Future Market Share (%), 2024
Figure 11: France Spinal Muscular Atrophy Market Size ($mn), 2016 - 2024
Figure 12: France Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Figure 13: France Spinal Muscular Atrophy Market Share by Drugs (%), 2019
Figure 14: France Spinal Muscular Atrophy Market - Future Market Share (%), 2024
Figure 15: Italy Spinal Muscular Atrophy Market Size ($mn), 2016 - 2024
Figure 16: Italy Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Figure 17: Italy Spinal Muscular Atrophy Market Share by Drugs (%), 2019
Figure 18: Italy Spinal Muscular Atrophy Market - Future Market Share (%), 2024
Figure 19: Spain Spinal Muscular Atrophy Market Size ($mn), 2016 - 2024
Figure 20: Spain Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Figure 21: Spain Spinal Muscular Atrophy Market Share by Drugs (%), 2019
Figure 22: Spain Spinal Muscular Atrophy Market - Future Market Share (%), 2024
Figure 23: UK Spinal Muscular Atrophy Market Size ($mn), 2016 - 2024
Figure 24: UK Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Figure 25: UK Spinal Muscular Atrophy Market Share by Drugs (%), 2019
Figure 26: UK Spinal Muscular Atrophy Market - Future Market Share (%), 2024
Figure 27: Europe Spinal Muscular Atrophy Market Size ($mn), 2016 - 2024
Figure 28: Europe Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Figure 29: Europe Spinal Muscular Atrophy Market Share by Drugs (%), 2019
Figure 30: Europe Spinal Muscular Atrophy Market - Future Market Share (%), 2024
Figure 31: Japan Spinal Muscular Atrophy Market Size ($mn), 2016 - 2024
Figure 32: Japan Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Figure 33: Japan Spinal Muscular Atrophy Market Share by Drugs (%), 2019
Figure 34: Japan Spinal Muscular Atrophy Market - Future Market Share (%), 2024
Figure 35: Global Spinal Muscular Atrophy Market Size ($mn), 2016 - 2024
Figure 36: Global Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Figure 37: Global Spinal Muscular Atrophy Market Share by Drugs (%), 2019
Figure 38: Global Spinal Muscular Atrophy Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll